Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04808362
Title Phase 1/2 Study to Evaluate Safety, PK and Efficacy of the MYC-Inhibitor OMO-103 in Solid Tumours (MYCure)
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Peptomyc S.L.
Indications

Advanced Solid Tumor

colorectal cancer

triple-receptor negative breast cancer

lung non-small cell carcinoma

Therapies

OMO-103

Age Groups: adult | senior
Covered Countries ESP

Additional content available in CKB BOOST